Stephen L. Hasak

Dr. Stephen L. Hasak


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Diseases
Verified
Journal Article
Open access
PDF file
PTPatrick Joseph Tempera
Patrick Joseph Tempera
MMMark Michael
Mark Michael
OTOmar Tageldin
Omar Tageldin
SHStephen L. Hasak
Stephen L. Hasak
Helicobacter pylori is an established cause of many gastrointestinal pathologies including peptic ulcer disease, gastritis, and gastric cancer. It is an entity that affects the global population, and its true nature has only been known since the 1980s. Although there is much known about H. pylori including its pathophysiology, detection, and eradication, resistance to current therapy models is common. This is problematic because untreated or inadequately treated H. pylori increases morbidity and mortality related to gastric cancer and peptic ulcer disease among others. In order to improve the treatment and reduce resistance, there is significant ongoing research identifying new detection and eradication methods for H. pylori. This review aims to highlight what has already been established regarding H. pylori’s epidemiology, pathophysiology, detection, and treatment as well as the most current and novel research involving detection and treatment of H. pylori.

8 February 2025 in Current Gastroenterology Reports
Verified
Journal Article
Closed access
PDF file
AAAhmad Abulawi
Ahmad Abulawi
SHStephen L. Hasak
Stephen L. Hasak
RTRicardo Marrero Torres
Ricardo Marrero Torres
HGHarishankar Gopakumar
Harishankar Gopakumar
SRSeth Richter
Seth Richter
NSNeil Sharma
Neil Sharma

30 October 2025 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
AAAhmad Abulawi
Ahmad Abulawi
JLJacqueline Liu
Jacqueline Liu
RARaya Alashram
Raya Alashram
MCMadeline Cleary
Madeline Cleary
SSSonia Samuel
Sonia Samuel
SRSeth Richter
Seth Richter
Background and aims: Colorectal cancer is the second leading cause of cancer death in the United States, yet ∼25% of patients undergoing colonoscopy have suboptimal bowel preparation. Bowel preparation is cited as the leading deterrent to an elective colonoscopy. Methods: This randomized, controlled, single-blinded noninferiority trial assessed the efficacy, safety, and patient tolerability of oral sulfate tablets (OST) compared with polyethylene glycol (PEG) based bowel preparation formulations, with explicit consideration of patient satisfaction and adverse events. Between March and August 2024, adult outpatients at Albany Medical Center requiring routine colonoscopies were consented and enrolled. Endoscopists were blinded to preparation assignments and graded the cleansing of the colon based on the US FDA Bowel Prep Scoring Scale. Patients completed a preparation satisfaction questionnaire. Results: This study assessed 177 patients (n=94 OST/n=83 PEG). Overall cleansing scores favored OST with 67.0% “excellent” preparations versus 57.8% for PEG. Although differences were not statistically significant in segmental analyses, trends favored OST. Generally, bowel preparation cleansing scores for the proximal, mid, and distal colon were numerically better for OST. Polyp identification was higher for OST (60.6%) versus PEG (54.2%). Tolerability favored OST, with 18.1% of patients in the OST group reporting adverse events (AE) versus 65.1% of patients in the PEG group. The most common AE for both groups was nausea. OST was “tolerable” to “very easy” to consume in 88.3% of patients compared with 78.6% for patients in the PEG group. OST was again requested by 92.6% of patients, compared with 60.7% of patients in the PEG group. Conclusions: This real-world study demonstrates the noninferior efficacy and safety of OST compared with conventional PEG-based formulations while highlighting improved patient tolerability, palatability, and potential preference bias due to free-of-charge provision.

1 January 2025
Verified
Book Chapter
Closed access
PDF file
UMUmer Malik
Umer Malik
BABilal Ashraf
Bilal Ashraf
SSSonia B. Samuel
Sonia B. Samuel
SHStephen L. Hasak
Stephen L. Hasak